Scarless circular mRNA-based CAR-T cell therapy elicits superior antitumor efficacy
Qinchao Hu, Hui Zhao, Kaicheng Zhou, Xuefei Tian, Qian Wang, Xianxin Hua, Xuyao Zhang · 2025
Read Scarless circular mRNA-based CAR-T cell therapy elicits superior antitumor efficacy by Qinchao Hu, Hui Zhao, Kaicheng Zhou, Xuefei Tian, Qian Wang, Xianxin Hua, Xuyao Zhang (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12722250.txt.
Description
Qinchao Hu and six co-authors engineer immune cells with ring-shaped messages in a 2025 cancer study. The cells, called CAR-T cells, are fitted with a catcher that hunts cancer. Making them with RNA instead of viruses is safer, but straight RNA strands break down fast, so the catcher fades in days.
The team built a platform that sews the RNA into clean rings with no scar at the join. Rings lasted longer in cells and drove stronger, longer catcher output than straight strands. The clean join also simplifies making the product and may stir the innate immune alarms less. In tumor tests, ring-made cells beat straight-RNA cells. The authors pitch rings for cancer and for non-cancer uses where a brief cell boost is wanted.
Catalog record
| CREATOR | Qinchao Hu, Hui Zhao, Kaicheng Zhou, Xuefei Tian, Qian Wang, Xianxin Hua, Xuyao Zhang |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 59 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |